An evaluation of sialation of the nucleoporin p62. (1998)
Fang B, Hanover J, Miller M
Arch Biochem Biophys, 1998 vol.357:95-100
SNFG,
Text,
Oxford
taxonomy (4)
protein (4)
source (7)
structure (1)
composition (1)
disease (2)
reference (1)
site (4)
peptide (0)
- Homo sapiens (Human)
- Mus musculus (House mouse)
- Rattus norvegicus (Norway rat)
- Xenopus laevis (African clawed frog)
Taxonomy
- Nucleoporin p62 / Homo sapiens P37198
- Nucleoporin p62 / Mus musculus
- Nuclear pore glycoprotein p62 / Rattus norvegicus P17955
- Nucleoporin p62 / Xenopus laevis
Protein
- Brain (UBERON_0000955) C-1300 clone N18 (CVCL_4724)
- Brain (UBERON_0000955) C-1300 clone S20 (CVCL_VU14)
- Brain (UBERON_0000955) NB41A3 (CVCL_3553)
- Brain (UBERON_0000955) Neuro-2a (CVCL_0470)
- Kidney (UBERON_0002113) NRK (CVCL_3758)
- Uterine Cervix (UBERON_0000002) HeLa (CVCL_0030) Fibroblast (CL_0000057)
- Egg Cell
Source
- O-Linked / O-GlcNAc / GlcNAc(b
Reported structure
- HexNAc:1 (avg mass : 221.2103 )
Composition
- Carcinoma (DOID:305)
- Neuroblastoma (DOID:769)
Disease
-
Nucleoporin p62 / Homo sapiens
- Undefined site
-
Nucleoporin p62 / Mus musculus
- Undefined site
-
Nuclear pore glycoprotein p62 / Rattus norvegicus
- Undefined site
-
Nucleoporin p62 / Xenopus laevis
- Undefined site
Reported glycosite
Mass spectrometry observed peptide
-
- O-Linked / O-GlcNAc
(avg mass : 221.2103)
- Brain (UBERON_0000955) C-1300 clone N18 (CVCL_4724)
- Brain (UBERON_0000955) C-1300 clone S20 (CVCL_VU14)
- Brain (UBERON_0000955) NB41A3 (CVCL_3553)
- Brain (UBERON_0000955) Neuro-2a (CVCL_0470)
- Kidney (UBERON_0002113) NRK (CVCL_3758)
- Uterine Cervix (UBERON_0000002) HeLa (CVCL_0030) Fibroblast (CL_0000057)
- Egg Cell
- Carcinoma (DOID:305)
- Neuroblastoma (DOID:769)
-
Nucleoporin p62 / Homo sapiens
- Undefined site
-
Nucleoporin p62 / Mus musculus
- Undefined site
-
Nuclear pore glycoprotein p62 / Rattus norvegicus
- Undefined site
-
Nucleoporin p62 / Xenopus laevis
- Undefined site
Source
Disease
Reported glycosite
- O-Linked / O-GlcNAc
(avg mass : 221.2103)